Navidea Biopharmaceuticals to Present at the Future Leaders in the Biotech Industry Conference

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Dr. Mark Pykett, Navidea’s President and Chief Executive Officer, will participate at the Future Leaders in the Biotech Industry Conference on April 5, 2013 at the Millennium Broadway Hotel & Conference Center, New York, NY. Dr. Pykett will provide an update of the Company and its development programs at 9:30 AM EDT.